We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy

By LabMedica International staff writers
Posted on 20 Mar 2025

Lung cancer continues to be the leading cause of cancer-related deaths globally, with survival rates heavily dependent on early detection and timely intervention. More...

However, diagnosing small, peripheral lung nodules remains a significant challenge, often leading to inconclusive biopsies and treatment delays. Now, a new collaboration aims to integrate real-time optical imaging into biopsy workflows, providing physicians with immediate insights at the point of care and enabling a deeper understanding of tissue microstructure that could support future advancements in artificial intelligence (AI)-driven analysis.

Stanford Medicine (Stanford, CA, USA) and LEADOPTIK Inc. (San Jose, CA, USA) have entered into a research collaboration to explore the use of AI-enhanced real-time optical imaging in lung biopsy procedures. This partnership will evaluate how high-resolution imaging can improve lesion assessment and biopsy accuracy while also contributing to the advancement of smart tools designed to support clinical decision-making. LEADOPTIK is developing technology that provides high-resolution, real-time visualization directly to physicians. The imaging data collected through this collaboration will help refine the application of advanced analytics, further supporting clinical adoption of intelligent imaging solutions.

Stanford Medicine's Interventional Pulmonology Program will play a leading role in evaluating this technology's potential for lung biopsy procedures. Stanford will assess how high-resolution microstructural visualization, combined with emerging AI-powered image interpretation, can refine sample collection strategies and improve patient outcomes. By analyzing detailed optical imaging data in real-world clinical settings, the collaboration aims to enhance diagnostic precision and lay the foundation for more intelligent, image-guided decision-making.

"Stanford Medicine is committed to evaluating and advancing technologies that have the potential to transform patient care," said Dr. Harmeet Bedi, Director of Interventional Pulmonology. "This collaboration allows us to assess whether real-time optical imaging, paired with data-driven insights, can enhance lung cancer diagnostics and improve biopsy precision."

"This partnership with Stanford marks an important step in further validating our unique real-time imaging and exploring how advanced image analysis can further support physicians," added Reza Khorasaninejad, CEO of LEADOPTIK. "By combining cutting-edge imaging with emerging smart tools, we aim to improve the precision of lung biopsy procedures and enable more confident clinical decision-making."

Related Links:
Stanford Medicine
LEADOPTIK Inc.


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Rapid Test Reader
DIA5000
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.